RI 36 (Oxymorphone hydrochloride extended-release 7.5 mg)
Pill imprint RI 36 has been identified as Oxymorphone hydrochloride extended-release 7.5 mg.
Oxymorphone is used in the treatment of pain; labor pain and belongs to the drug class narcotic analgesics. Risk cannot be ruled out during pregnancy. Oxymorphone 7.5 mg is classified as a Schedule 2 controlled substance under the Controlled Substance Act (CSA).
- Imprint:
- RI 36
- Strength:
- 7.5 mg
- Color:
- Gray
- Shape:
- Round
- Availability:
- Prescription only
- Drug Class:
- Narcotic analgesics
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- 2 - High potential for abuse
- Manufacturer:
- Ranbaxy Pharmaceuticals Inc.
More about oxymorphone
Consumer resources
- Oxymorphone
- Oxymorphone extended-release tablets
- Oxymorphone suppositories
- Oxymorphone tablets
- Oxymorphone (Advanced Reading)
- Oxymorphone Injection (Advanced Reading)
Professional resources
Related treatment guides
Disclaimer:
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.
